cGxP.wire https://validator.w3.org/feed/docs/rss2.html Tectonic Therapeutic Advances TX2100 in HHT With FDA Fast Track LEO Pharma Reports New Tralokinumab Data in Atopic Dermatitis Roche Reports Positive Phase III Giredestrant Results in Advanced Breast Cancer LEO Pharma Presents New Delgocitinib Data in Chronic Hand Eczema Samsung Bioepis and Teva Expand Biosimilar Partnership Atsena Reports 18-Month ATSN-201 Results in XLRS Roche Reports Real-World Vabysmo Data Across Major Retinal Conditions Zealand Pharma Reports Phase III Survodutide Results in Obesity and Type 2 Diabetes Atrogi Reports Positive Human Data for ATR-258 Boehringer Ingelheim Reports Phase III Survodutide Data in Obesity and T2D Moleculin Reports Positive MIRACLE Interim Results in R/R AML Phathom Advances VOQUEZNA in Non-Erosive GERD Nasus Pharma Advances NS003 Intranasal Ondansetron Into Phase 1 Corbus Advances CRB-701 in 2L+ Oropharyngeal Cancer argenx Reports New VYVGART Data in Myasthenia Gravis and CIDP Acurx Enrolls First Patient in Ibezapolstat Trial Novo Nordisk Reports Real-World Wegovy Pill Data AbbVie Advances Zumilokibart in Atopic Dermatitis Airway Therapeutics Wins $1.9M NIH Grant for Zelpultide Syra Health Wins Three-Year Mississippi Public Health Award GT Medical Technologies Reports Phase 3 GammaTile Data Vanda Pharmaceuticals Reports Phase III HETLIOZ Results AbbVie Advances ABBV-295 With Phase 1 Obesity Data Cytrellis Expands ellacor Micro-Coring Technology to Korea UTR Therapeutics Gains FDA Designations for UTRxMYCN XYone Therapeutics Doses First Patient With XYA02 ADC Cepheid Wins FDA Clearance for Xpert Respiratory Panel Egetis Therapeutics Wins FDA Approval for EMCITATE Eli Lilly Retatrutide Shows Strong Weight Loss and A1C Genentech Fenebrutinib FDA Filing Accepted for Multiple Sclerosis AbbVie Reports Positive Phase 2 Zumilokibart Atopic Dermatitis Results Takeda Reports Phase 3 Zasocitinib Psoriasis Results Oncolytics Reports Pelareorep Data Supporting Immune Activation in Liver Cancer Boehringer Ingelheim Commits €500M to Health and Sustainability Dyne Therapeutics Reports One-Year Z-Basivarsen Data in DM1 Zealand Pharma Reports Petrelintide Phase 2 ZUPREME-1 Data Akeso Advances Cadonilimab in Global Gastric Cancer Trial DBV Technologies Submits BLA for VIASKIN Peanut Patch GPN Vaccines Advances Serotype-Independent Bacterial Vaccine Platform AnaCardio Raises €62.5 Million Series B for AC01 Roche Gains FDA Priority Review for Fenebrutinib in Multiple Sclerosis Egle Therapeutics Reports Phase 1 EGL-003 Treg Expansion Data Eli Lilly Reports Zepbound Weight-Loss Comparison Data Italfarmaco Reports Long-Term Givinostat Upper Limb Data in DMD Hummingbird Bioscience Doses First Patient in HMBD-001 Phase II Trial VectorY Expands PIONEER-ALS Trial to 36 Participants Aldeyra Plans FDA Dispute Resolution Request for Reproxalap Zai Lab to Present Global Zoci Data in First-Line ES-SCLC Nurix Therapeutics Reaches $7 Million Pfizer Collaboration Milestone Immix Biopharma Reports 89% Complete Response Rate With NXC-201